Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - P/B ratio
P/B ratio as of May 2024 : 4.75
According to Marinus Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.75.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Marinus Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 35.4 | 1978.48% |
| 2022-12-31 | 1.70 | -79.16% |
| 2021-12-31 | 8.17 | 151.07% |
| 2020-12-31 | 3.25 | 52.81% |
| 2019-12-31 | 2.13 | -3.5% |
| 2018-12-31 | 2.21 | -61.3% |
| 2017-12-31 | 5.70 | 515.17% |
| 2016-12-31 | 0.9266 | -70.65% |
| 2015-12-31 | 3.16 | -12.24% |
| 2014-12-31 | 3.60 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 1.81 | -61.99% | 🇺🇸 USA |
 Endo International
ENDPQ | 0.0000 | -100.00% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | 1.03 | -78.24% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | 0.2262 | -95.24% | 🇺🇸 USA |